Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1961 2
1962 1
1963 1
1964 1
1965 1
1969 1
1970 1
1971 1
1972 5
1973 2
1974 6
1975 9
1976 11
1977 7
1978 11
1979 14
1980 7
1981 9
1982 9
1983 3
1984 8
1985 11
1986 3
1987 7
1988 6
1989 2
1990 3
1991 3
1992 2
1993 6
1994 7
1995 3
1996 15
1997 19
1998 12
1999 13
2000 22
2001 18
2002 15
2003 12
2004 16
2005 31
2006 17
2007 18
2008 17
2009 6
2010 10
2011 16
2012 13
2013 11
2014 5
2015 8
2016 8
2017 6
2018 4
2019 5
2020 10
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

474 results

Results by year

Filters applied: . Clear all
Page 1
Hemagglutinating Virus of Japan Envelope (HVJ-E)-Guided Gene Transfer to the Intestinal Epithelium.
Imajo M. Imajo M. Methods Mol Biol. 2020;2171:285-291. doi: 10.1007/978-1-0716-0747-3_19. Methods Mol Biol. 2020. PMID: 32705650
The method, termed intestine-specific gene transfer (iGT), enables rapid and efficient delivery of small molecules, such as siRNAs and plasmids, into the intestinal epithelium of living mice by utilizing the hemagglutinating virus of Japan envelope ( …
The method, termed intestine-specific gene transfer (iGT), enables rapid and efficient delivery of small molecules, such as siRNAs and plasm …
Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
Sugii N, Matsuda M, Okumura G, Shibuya A, Ishikawa E, Kaneda Y, Matsumura A. Sugii N, et al. Cancer Sci. 2021 Jan;112(1):81-90. doi: 10.1111/cas.14721. Epub 2020 Nov 25. Cancer Sci. 2021. PMID: 33155337 Free PMC article.
To develop effective combination therapy involving PD-1/PD-L1 inhibition, we used a non-replicating virus-derived vector, hemagglutinating virus of Japan-envelope (HVJ-E), to inhibit tumor cell PD-L1 expression by delivering siRNA targeti …
To develop effective combination therapy involving PD-1/PD-L1 inhibition, we used a non-replicating virus-derived vector, hemagglu …
Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
Kaneda Y. Kaneda Y. Expert Opin Drug Deliv. 2008 Feb;5(2):221-33. doi: 10.1517/17425247.5.2.221. Expert Opin Drug Deliv. 2008. PMID: 18248320 Review.
This can enable efficient drug delivery and gene expression, while reducing the cytotoxicity of the various vector components. METHODS: The Hemagglutinating Virus of Japan (HVJ; Sendai virus) envelope vector was developed using fus …
This can enable efficient drug delivery and gene expression, while reducing the cytotoxicity of the various vector components. METHODS: The …
Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy.
Yoneoka S, Nakagawa Y, Uto K, Sakura K, Tsukahara T, Ebara M. Yoneoka S, et al. Sci Technol Adv Mater. 2019 Mar 29;20(1):291-304. doi: 10.1080/14686996.2019.1586051. eCollection 2019. Sci Technol Adv Mater. 2019. PMID: 30956733 Free PMC article.
Combining immunotherapeutic and radiotherapeutic technique has recently attracted much attention for advancing cancer treatment. If boron-incorporated hemagglutinating virus of Japan-envelope (HVJ-E) having high membrane fusion ability can be us …
Combining immunotherapeutic and radiotherapeutic technique has recently attracted much attention for advancing cancer treatment. If boron-in …
Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study.
Sakura K, Sasai M, Funaki S, Shintani Y, Okumura M, Kaneda Y. Sakura K, et al. Cancers (Basel). 2023 Feb 1;15(3):929. doi: 10.3390/cancers15030929. Cancers (Basel). 2023. PMID: 36765886 Free PMC article.
However, recently, immune checkpoint inhibitors (ICIs) are also used. For better efficacy of MPM treatment, we focused on hemagglutinating virus of Japan envelope (HVJ-E), which activates antitumor immunity and induces tumor-specific cell death. …
However, recently, immune checkpoint inhibitors (ICIs) are also used. For better efficacy of MPM treatment, we focused on hemagglutinatin …
Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, Saito A, Sakura K, Nakajima T, Myoui A, Sakurai T, Kawakami Y, Kaneda Y, Katayama I. Kiyohara E, et al. Cancer Immunol Immunother. 2020 Jun;69(6):1131-1140. doi: 10.1007/s00262-020-02509-8. Epub 2020 Feb 11. Cancer Immunol Immunother. 2020. PMID: 32047956 Free PMC article. Clinical Trial.
Hemagglutinating virus of Japan (HVJ; Sendai virus) is an RNA virus that has cell fusion activity. HVJ-envelope (HVJ-E) is a UV-irradiated HVJ particle that loses viral replication and protein synthesis …
Hemagglutinating virus of Japan (HVJ; Sendai virus) is an RNA virus that has cell fu …
Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth.
Lee CH, Nishikawa T, Kaneda Y. Lee CH, et al. Oncotarget. 2017 May 23;8(21):35048-35060. doi: 10.18632/oncotarget.17037. Oncotarget. 2017. PMID: 28456782 Free PMC article.
Salmonella can target to tumor microenvironments after systemic treatment. The hemagglutinating virus of Japan-envelope (HVJ-E) induced apoptosis in tumor cells without toxicity in normal cells. ...Treatment with P-HVJ-E resulted in decre …
Salmonella can target to tumor microenvironments after systemic treatment. The hemagglutinating virus of Japan-e …
Nano-decoration of the Hemagglutinating Virus of Japan envelope (HVJ-E) using a layer-by-layer assembly technique.
Okada T, Uto K, Sasai M, Lee CM, Ebara M, Aoyagi T. Okada T, et al. Langmuir. 2013 Jun 18;29(24):7384-92. doi: 10.1021/la304572s. Epub 2013 Mar 7. Langmuir. 2013. PMID: 23441859
In this study, we created a nanoscale layer of hyaluronic acid (HA) on the inactivated Hemagglutinating Virus of Japan envelope (HVJ-E) via a layer-by-layer (LbL) assembly technique for CD-44 targeted delivery. HVJ-E was selected as the t …
In this study, we created a nanoscale layer of hyaluronic acid (HA) on the inactivated Hemagglutinating Virus of Jap …
Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates.
Tsuboniwa N, Morishita R, Hirano T, Fujimoto J, Furukawa S, Kikumori M, Okuyama A, Kaneda Y. Tsuboniwa N, et al. Hum Gene Ther. 2001 Mar 20;12(5):469-87. doi: 10.1089/104303401300042366. Hum Gene Ther. 2001. PMID: 11268281
We tested, in cynomolgus monkeys, the safety and effectiveness of a hybrid liposome vector, hemagglutinating virus of Japan (HVJ)--artificial viral envelope (AVE) liposomes, for human therapeutic gene transfer in a series of experiments. ...Howe …
We tested, in cynomolgus monkeys, the safety and effectiveness of a hybrid liposome vector, hemagglutinating virus of …
Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration-resistant prostate cancer.
Fujita K, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Okihara K, Ukimura O, Miki T, Nakajima T, Kaneda Y, Nonomura N. Fujita K, et al. Cancer Sci. 2020 May;111(5):1692-1698. doi: 10.1111/cas.14366. Epub 2020 Mar 19. Cancer Sci. 2020. PMID: 32112659 Free PMC article. Clinical Trial.
Inactivated hemagglutinating virus of Japan envelope (HVJ-E) has an antitumor effect and tumor immunity. We undertook an open-label, phase I, dose-escalation study in patients with castration-resistant prostate cancer (CRPC) to determine the saf …
Inactivated hemagglutinating virus of Japan envelope (HVJ-E) has an antitumor effect and tumor immunity. …
474 results